Efficacy of topical isotretinoin 0.05% gel in acne vulgaris: Results of a multicenter, double-blind investigation

Dan K. Chalker, Jack L Lesher, J. Graham Smith

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Two hundred sixty-eight patients with mild to moderate acne vulgaris completed a multicenter, double-blind, controlled study comparing isotretinoin 0.05% gel with its vehicle. Patients were treated twice daily for up to 14 weeks. Efficacy was measured by counting facial inflammatory and noninflammatory lesions and by grading acne severity initially and at 2- to 3-week intervals throughout the study. The isotretinoin 0.05% gel proved to be statistically more effective than vehicle in reducing inflammatory lesions after 5 weeks and in reducing noninflammatory lesions and acne severity grade after 8 weeks. Except for two patients who dropped out because of irritation, isotretinoin 0.05% gel was well tolerated.

Original languageEnglish (US)
Pages (from-to)251-254
Number of pages4
JournalJournal of the American Academy of Dermatology
Volume17
Issue number2
DOIs
StatePublished - Jan 1 1987

Fingerprint

Isotretinoin
Acne Vulgaris
Gels
Double-Blind Method

ASJC Scopus subject areas

  • Dermatology

Cite this

Efficacy of topical isotretinoin 0.05% gel in acne vulgaris : Results of a multicenter, double-blind investigation. / Chalker, Dan K.; Lesher, Jack L; Smith, J. Graham.

In: Journal of the American Academy of Dermatology, Vol. 17, No. 2, 01.01.1987, p. 251-254.

Research output: Contribution to journalArticle

@article{350453610f2748578652ba3748344d14,
title = "Efficacy of topical isotretinoin 0.05{\%} gel in acne vulgaris: Results of a multicenter, double-blind investigation",
abstract = "Two hundred sixty-eight patients with mild to moderate acne vulgaris completed a multicenter, double-blind, controlled study comparing isotretinoin 0.05{\%} gel with its vehicle. Patients were treated twice daily for up to 14 weeks. Efficacy was measured by counting facial inflammatory and noninflammatory lesions and by grading acne severity initially and at 2- to 3-week intervals throughout the study. The isotretinoin 0.05{\%} gel proved to be statistically more effective than vehicle in reducing inflammatory lesions after 5 weeks and in reducing noninflammatory lesions and acne severity grade after 8 weeks. Except for two patients who dropped out because of irritation, isotretinoin 0.05{\%} gel was well tolerated.",
author = "Chalker, {Dan K.} and Lesher, {Jack L} and Smith, {J. Graham}",
year = "1987",
month = "1",
day = "1",
doi = "10.1016/S0190-9622(87)70200-X",
language = "English (US)",
volume = "17",
pages = "251--254",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Efficacy of topical isotretinoin 0.05% gel in acne vulgaris

T2 - Results of a multicenter, double-blind investigation

AU - Chalker, Dan K.

AU - Lesher, Jack L

AU - Smith, J. Graham

PY - 1987/1/1

Y1 - 1987/1/1

N2 - Two hundred sixty-eight patients with mild to moderate acne vulgaris completed a multicenter, double-blind, controlled study comparing isotretinoin 0.05% gel with its vehicle. Patients were treated twice daily for up to 14 weeks. Efficacy was measured by counting facial inflammatory and noninflammatory lesions and by grading acne severity initially and at 2- to 3-week intervals throughout the study. The isotretinoin 0.05% gel proved to be statistically more effective than vehicle in reducing inflammatory lesions after 5 weeks and in reducing noninflammatory lesions and acne severity grade after 8 weeks. Except for two patients who dropped out because of irritation, isotretinoin 0.05% gel was well tolerated.

AB - Two hundred sixty-eight patients with mild to moderate acne vulgaris completed a multicenter, double-blind, controlled study comparing isotretinoin 0.05% gel with its vehicle. Patients were treated twice daily for up to 14 weeks. Efficacy was measured by counting facial inflammatory and noninflammatory lesions and by grading acne severity initially and at 2- to 3-week intervals throughout the study. The isotretinoin 0.05% gel proved to be statistically more effective than vehicle in reducing inflammatory lesions after 5 weeks and in reducing noninflammatory lesions and acne severity grade after 8 weeks. Except for two patients who dropped out because of irritation, isotretinoin 0.05% gel was well tolerated.

UR - http://www.scopus.com/inward/record.url?scp=0023224150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023224150&partnerID=8YFLogxK

U2 - 10.1016/S0190-9622(87)70200-X

DO - 10.1016/S0190-9622(87)70200-X

M3 - Article

C2 - 2957398

AN - SCOPUS:0023224150

VL - 17

SP - 251

EP - 254

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 2

ER -